Dow Up 0.92% Nasdaq Up 1.21%

AcelRx Pharmaceuticals, Inc. (ACRX)

-NasdaqGM
6.68 Down 0.26(3.75%) 2:44PM EDT - Nasdaq Real Time Price
Prev Close:6.94
Open:7.00
Bid:6.68 x 1000
Ask:6.69 x 1100
1y Target Est:11.33
Beta:2.16
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:6.65 - 7.00
52wk Range:5.22 - 13.64
Volume:292,947
Avg Vol (3m):703,682
Market Cap:289.76M
P/E (ttm):N/A
EPS (ttm):-0.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ACRX

Comparison

Symbol% ChgMkt Cap
ACRXDown 3.75%289.76M
BAXDown 0.14%37.90B
CFNUp 0.15%11.69B
HSPDown 1.47%9.02B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):10.63
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.07
Quarterly EPS Est (Sep-14) :-0.22
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AcelRx Pharmaceuticals, Inc., a development stage specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute and breakthrough pain (BTP). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback